期刊文献+

S期激酶相关蛋白2与恶性血液病

S-phase kinase associated protein2and hematologic malignancies
暂未订购
导出
作者 韩利杰
出处 《河南医学研究》 CAS 2006年第1期89-91,94,共4页 Henan Medical Research
  • 相关文献

参考文献27

  • 1Schulman BA,Carrano AC,Jeffrey PD,et al.Insights into SCF ubiquitin ligases from the structure of the skp1-skp2 complex [ J ].Nature,2000,408(6810):381-386.
  • 2Pagano M.Control of DNA synthesis and mitosis by the Skp2-p27-Cdk1/2axis[J].Mol Cell,2004,14(4):414-416.
  • 3Spruck CH,Strohmaier HM.Seek and destroy:SCF ubiquitin ligases in mammalian cell cycle control[ J].Cell cycle,2002,1 (4):250-254.
  • 4Ungermannova D,Gao Y,Liu X.Ubiquitination of p27 Kip1 requires physical interaction with cyclinE and probable phosphate recognition by SKP2[J].J Biol Chem,2005,280 (34):30301-30309.
  • 5Hao B,Zheng N,Schulman BA,et al.Structural basis of the Cks1-dependent recognition of p27(Kip1) by the SCF(Skp2) ubiquitin ligase[J].Mol Cell,2005,20(1):9-19.
  • 6Harper JW.Protein destruction:Adapting roles for Cks proteins[ J].Curr Biol,2001,11 (11):431-435.
  • 7Sitry D,Seeliger MA,Ko TK,et al.Three different binding sites of Cks1are required for p27-ubiquitin ligation [ J ].J Biol Chem,2002,277 (44):42233-42240.
  • 8Kitajima S,Kudo Y,Ogawa I,et al.Role of Cks1 overexpression in oral squamous cell carcinomas:cooperation with Skp2 in promoting p27 degradation[J].Am J Pathol,2004,165(6):2147-2155.
  • 9Ji P,Zhu L.Using kinetic studies to uncover new Rb functions in inhibiting cell cycle progression [ J ].Cell Cycle,2005,4 (3):373-375.
  • 10Ji P,Jiang H,Rekhtman K,et al.An Rb-Skp2-p27 pathway mediates acute cell cycle inhibition by Rb and is retained in a partial-penetrance Rb mutant[J].Mol Ce11,2004,16(1):47-58.

二级参考文献12

  • 1Deininger MW, Goldman JM, Melo JV. The molecular biology of chronic myeloid leukemia[J]. Blood, 2000, 96:3343 - 3356.
  • 2Jonuleit T, Van der Kuip H, Miething C, et al. BCR-ABL kinase down-regulates cyclin-dependent kinase inhibitor p27 in human and murine cell lines[J]. Blood, 2000, 96:1933 - 1939.
  • 3Pagano M, Tam SW, Theodoras AM, et al. Role of the ubiquitin-proteosome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27 [J]. Science, 1995, 269:682 - 685.
  • 4Carrana AC, Eytan E, Hershko A, et al. Skp2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27 [J]. Nat Cell Biol, 1999, 1:193 - 199.
  • 5Skorski T, Szczylik C, Malaguamera L, et al. Gene-targeted specific inhibition of chronic myeloid leukemla cell growth by BCR-ABL antisense oligodeoxynucleotides[J]. Folia Histochem Cytobiol, 1991, 29:85 - 89.
  • 6Gewirtz AM. Treatment of chronic myelogenous leukemia (CML)with c-myb antisense oligodeoxynucleotides[J]. Bone Marrow Transplant, 1994,14 Suppl 3:S57 - S61.
  • 7Algar EM, Khromykh T, Smith SI, et al. A WT1 antisense oligonucleotide inhibits proliferation and induces apoptesis in myeloid leukaemia cell lines[J]. Oncogene, 1996, 12:1005 -1014.
  • 8Few ML, Randel E, Gurley KE, et al. The murine genep 27Kip1 is haplo-insufficient for tumour suppression[J]. Nature,1998, 396:177 - 180.
  • 9Nakayama KI, Hatakeyama S, Nakayama K. Regulation of the cell cycle at the G1-S transition by proteolysis of Cyclin E and p27KIP1[J] . Biochem and Biophys Res Commun, 2001, 282:853 - 860.
  • 10Gstaiger M, Jordan R, Lim M, et al. Skp2 is oncogenic and overexpressed in human cancers[J]. Proc Natl Acad Sci USA,2001, 98:5043 - 5048.

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部